The U.S. government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under ...

The U.S. government said on Wednesday it will consider opportunities to "bring greater transparency" for the Medicare drug ...

Veru said on Monday its experimental drug, in combination with Novo Nordisk's weight-loss treatment Wegovy, helped preserve muscle in older patients with obesity, meeting the main goal of a mid-stage ...

Johnson & Johnson , fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular , reported fourth-quarter ...

Bhanvi Satija reports on pharmaceutical companies and the healthcare industry in the United States. She has a postgraduate degree in International Journalism from City, University of London.

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...

J&J Beats Quarterly Sales and Profit Estimates on Cancer Drug Sales By Patrick Wingrove and Bhanvi Satija (Reuters) - Johnson & Johnson, fresh off a $14.6 billion deal to buy neurological ...

UnitedHealth's quarterly medical cost ratio — the percentage of premiums spent on medical care — stood at 87.6%, compared with estimates of 85.95%, according to data compiled by LSEG. Companies ...

Medicare price talks target 15 expensive drugs for 2027 PhRMA criticizes Medicare price negotiation process as stifling innovation Makers of selected drugs have until Feb. 28 to decide if they ...

UnitedHealth Group CEO Says Complex US Healthcare System Needs to Change By Sriparna Roy and Bhanvi Satija (Reuters) -UnitedHealth CEO Andrew Witty said on Thursday that healthcare in the U.S ...